MIUC: Risk of Recurrence After Radical Cystectomy
An expert discusses how patients with muscle-invasive urothelial carcinoma (MIUC) undergoing radical cystectomy face a significant recurrence risk. High-risk factors include advanced stage, lymph node involvement, and positive surgical margins. Neoadjuvant cisplatin-based chemotherapy can improve survival but does not eliminate recurrence risk. Other predictors include lymphovascular invasion, variant histology, and systemic inflammation markers.
Video content above is prompted by the following:
- What is the risk of recurrence for patients with muscle-invasive urothelial carcinoma who undergo radical cystectomy with or without neoadjuvant cisplatin-based chemotherapy? (Renner 2021; Kim 2015; Bellmunt 2022)
- What factors put patients at higher risk for recurrence?
Recent Videos
Related Content
